NIO moves from self-developed automotive chips toward an AI chip platform

Overview

This report focuses on the first independent appearance of GeniTech (Shenji), the chip business under NIO Inc., at WAIC 2026. Morgan Stanley believes GeniTech is no longer merely a self-developed chip line serving NIO's internal intelligent driving needs, but is evolving into a full-domain AI silicon platform spanning intelligent driving, embodied intelligence, and agentic inference. This shift could transform past heavy R&D investment into an asset capable of external financing, licensing, and commercialization, thereby improving NIO's cost structure and equity narrative.

Core views

The core view is that NIO's share price recovery still depends on execution: on one hand, the NIO brand and Onvo need to continue boosting sales after the launch of models such as the new ES8 and Onvo L80; on the other hand, the company needs to reduce cash burn through restructuring, cost reduction, and R&D amortization. GeniTech's progress supports both of these main themes: internally supplied chips can reduce reliance on external high-end computing suppliers, while external financing and licensing may ease the group's R&D burden and help achieve the 2026 profitability target.

Analysis framework

The report uses a risk-reward framework and scenario-weighted valuation. The Hong Kong-listed target price is converted from the ADR target price using an HKD/USD exchange rate of 7.8; the ADR valuation assigns weights of 25%, 50%, and 25% to the bull, base, and bear cases, respectively. Key assumptions include a WACC of 17.8%, a beta of 2.4, and a terminal growth rate of 3.0%. Fundamental tracking focuses on sales ramp-up, new model launches, BaaS penetration, ADAS commercialization, operating efficiency, and improvement in cash burn.

Methodology notes

• Valuation methodsRisk-reward scenario-weighted valuation

  Bull/base/bear scenario weighting

  The report assigns 25%/50%/25% weights to different macro, competitive, and execution scenarios to derive the 12-18 month target price.

• Valuation methodsP/S multiple

  2026E P/S

  In the Hong Kong-listed risk-reward range, the bull, base, and bear cases use approximately 1.8x, 0.8x, and 0.3x 2026E P/S, respectively, corresponding to different assumptions for sales, margins, and ADAS commercialization.

• FundamentalsMorgan Stanley ModelWare

  Earnings forecast model

  Revenue, EPS, EBITDA, net profit, valuation multiples, and financial metrics are based on Morgan Stanley's ModelWare framework and its research estimates.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• NIO Inc. (9866.HK)

  Primary covered name

  Strengths

  Overweight rating, HK$58 target price, GeniTech platformization, self-developed chips reducing costs, and sales elasticity from Onvo and the new ES8.

  Weaknesses

  Still faces pressure from cash burn, sales execution, and margin recovery.

  Comparison

  Compared with traditional EV manufacturers, NIO has narratives around battery swapping, ADAS, and self-developed AI chips; but compared with more mature automakers, earnings visibility remains weaker.

  Risks

  Sales below expectations, pressure on ASP and gross margin, slow ADAS monetization, and industry valuation drag from slowing auto sales.

• NIO Inc. (NIO.N)

  ADR of the same company

  Strengths

  ADR target price of US$7.40, using the same fundamental and scenario-weighted framework.

  Weaknesses

  ADR valuation likewise depends on delivery of sales ramp-up and cost improvement.

  Comparison

  The Hong Kong-listed target price is converted from the ADR target price using a 7.8 exchange rate.

  Risks

  Exchange rates, market risk appetite, and the trading environment for Chinese ADRs may affect performance.

• GeniTech (Shenji)

  NIO-controlled AI chip business

  Strengths

  Covers intelligent driving, embodied intelligence, and agentic inference; has obtained external financing; and has potential for internal cost reduction and external licensing.

  Weaknesses

  External customers and robotics revenue are still in the ramp-up validation stage.

  Comparison

  The report says management positions it as a Chinese chipmaker spanning three categories of applications; the computing power of a single NX9031 chip is described as equivalent to four Nvidia Orin chips.

  Risks

  Commercialization progress, customer expansion, technology iteration, and chip competition may affect value realization.

Key data

• Hong Kong-listed target priceHK$58.00The target price implies 48% upside from the July 20, 2026 closing price of HK$39.26.
• ADR target priceUS$7.40The Hong Kong-listed target price is converted from the ADR target price using an HKD/USD exchange rate of 7.8.
• GeniTech financingNearly RMB 3 billionCumulative financing since the spin-off in June 2025.
• GeniTech valuationNearly RMB 8.3 billionPost-money valuation after external financing in February 2026.
• NIO shareholding ratioAbout 63%NIO still controls GeniTech, making the chip business a potential option value within the listed company.
• Cumulative NX9031X shipmentsMore than 300,000 unitsHas been installed in all NIO and Onvo models.
• NX9031U computing powerUp to 800 TOPS equivalent computing powerBased on the 5nm automotive-grade node and using an air-cooling solution.
• 2026E net revenueRmb128,580.1mnMorgan Stanley forecast.
• 2027E net profit inflection pointModelWare net income Rmb796.5mnThe base case in the risk-reward table shows a return to profitability in 2027.

Impact & implications

If GeniTech can validate external customers, robotics/embodied intelligence applications, and licensing revenue, NIO's investment narrative could shift in part from that of a cash-burning EV manufacturer to a vertically integrated AI chip platform. For the stock price, this provides a potential re-rating catalyst; for operations, self-developed chip mass production and external financing help amortize fixed R&D costs and improve gross margin and cash flow. However, short-term delivery still depends on sales ramp-up, cost control, and the pace of ADAS service commercialization.

Risks

• Sales, orders, and market share below expectations.
• ASP and vehicle gross margin coming under pressure due to weak demand or intensifying competition.
• ADAS service adoption, subscription pricing, and monetization potential below expectations.
• Limited improvement in operating efficiency, with cash burn declining more slowly than expected.
• A slowdown in auto industry sales growth may weigh on overall sector valuations.
• GeniTech's ramp-up in external customers, licensing revenue, and robotics/embodied intelligence business falling short of expectations.

What to watch

• Orders and deliveries after the launch of the new ES8 and Onvo L80.
• Sales ramp-up of the NIO brand and Onvo in 2026.
• Progress in GeniTech's external financing, customer signings, licensing, and robotics-related revenue.
• Shipment scale of the NX9031 series in NIO, Onvo, and third-party scenarios.
• ADAS service adoption, subscription pricing, and commercialization progress.
• Progress in operating expenses, capex, cash burn, and the 2026 profitability target.